Search results
Author(s):
Ralf Westenfeld
Added:
6 years ago
Author(s):
Karl Werdan
,
Martin Russ
,
Michael Buerke
,
et al
Added:
3 years ago
Cardiogenic Shock, One of the Unresolved Problems in Cardiology
Provided the patient with acute myocardial infarction (AMI) reaches the hospital, he has a more than 90 % probability to survive.1 However, when cardiogenic shock develops, either initially or in the course of the infarction, only one in two patients is alive one year later.2,3 It really seems that all the progress in the treatment…
View more
Author(s):
Andrew K Roy
,
John Keaney
,
Niall G Mahon
,
et al
Added:
3 years ago
The coexistence of heart and kidney disease represents an evolving epidemic in an ageing population, with chronic kidney disease (CKD) incidence rates increasing annually.1 The effect of dysfunction of one kidney mediates profound effects on the other, recently described and defined as five distinctive cardiorenal subtypes by the Acute Dialysis Quality Initiative consensus group.2 Much work has…
View more
Author(s):
Alexander G Truesdell
,
Behnam Tehrani
,
Ramesh Singh
,
et al
Added:
3 years ago
Considering the unacceptably high mortality rate of patients with cardiogenic shock (CS) and the absence of widespread improvements in survival over recent decades, the time has arrived for the cardiovascular community to embrace a ‘combat’ approach to CS.1 In the past 20 years we have witnessed a revolution in the management of combat polytrauma towards a goal of zero preventable battlefield…
View more
Author(s):
Dagmar M Ouweneel
,
Bimmer E Claessen
,
Krischan D Sjauw
,
et al
Added:
3 years ago
The main goal of mechanical cardiac assistance is to provide haemodynamic support in case of an endangered coronary or systemic circulation by increasing or maintaining coronary and systemic blood flow. In addition to haemodynamic support, mechanical cardiac assistance may also provide myocardial protection by unloading the ventricle. The experience with percutaneous mechanical support devices is…
View more
Author(s):
Katrina Mountfort
Added:
3 years ago
Hypertension is one of the most important public health problems of the 21st century, with a global prevalence of around 30 %.1 In 2010, it accounted for 7.5 million deaths worldwide, representing 12.8 % of the global total.2 Furthermore, its prevalence is projected to rise to 1.5 billion hypertensive patients in 2025.3 Despite the availability of numerous safe and effective antihypertensive…
View more
Author(s):
Robert J Henning
Added:
3 years ago
Myocardial infarction (MI) is the leading cause of death among people in the industrialised world and will, according to the World Health Organization (WHO), become the leading cause of death in the world in 2020.1 For the treatment of patients with MIs and ischaemic cardiomyopathies, remarkable medical advances have been made during the second half of the 20th Century that have increased patient…
View more
Author(s):
Joel P Giblett
,
Heerajnarain Bulluck
Added:
3 years ago
The translation to clinical practice of agents or techniques that protect against the effect of ischaemia–reperfusion (IR) injury remains one of the most challenging areas of research in the field of cardiovascular medicine.1–4 This is particularly the case when IR injury follows revascularisation for acute MI (AMI). The publication of the combined Effect of Remote Ischaemic Conditioning on…
View more
Author(s):
Jean-Pierre Bassand
Added:
3 years ago
Anticoagulants and antiplatelet therapies, and revascularisation/ reperfusion with percutaneous coronary interventions (PCIs) or surgery are the mainstay of modern treatment of acute coronary syndromes (ACS) with and without ST-segment elevation. In addition, depending on the clinical presentation, thrombolytic therapy may be necessary in patients with ST-elevation myocardial infarction (MI) who…
View more
Author(s):
Farouc Jaffer
Added:
5 years ago
Dr. Farouc Jaffer discussesProcedural Outcomes of Multiple CTO Intervention Carried Out in the Same Procedure: Insight From a Multicenter CTO Registry
Filmed by Radcliffe Cardiology on-site at ACC 2018 in Orlando, US.
View more